skip to main content
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Resultados 1 2 3 4 5 next page
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Corrigendum to: Interaction of transcription factor AP‐2 gamma with proto‐oncogene PELP1 promotes tumorigenesis by enhancing RET signaling
Material Type:
Artigo
Adicionar ao Meu Espaço

Corrigendum to: Interaction of transcription factor AP‐2 gamma with proto‐oncogene PELP1 promotes tumorigenesis by enhancing RET signaling

Molecular oncology, 2022-01, Vol.16 (1), p.307-307 [Periódico revisado por pares]

United States: John Wiley & Sons, Inc

Texto completo disponível

2
Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy
Material Type:
Artigo
Adicionar ao Meu Espaço

Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy

Skoulidis, Ferdinandos ; Heymach, John V

Nature reviews. Cancer, 2019-09, Vol.19 (9), p.495-509 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

3
Pan-cancer efficacy of pralsetinib in patients with RET fusion-positive solid tumors from the phase 1/2 ARROW trial
Material Type:
Artigo
Adicionar ao Meu Espaço

Pan-cancer efficacy of pralsetinib in patients with RET fusion-positive solid tumors from the phase 1/2 ARROW trial

Subbiah, Vivek ; Cassier, Philippe A ; Siena, Salvatore ; Garralda, Elena ; Paz-Ares, Luis ; Garrido, Pilar ; Nadal, Ernest ; Vuky, Jacqueline ; Lopes, Gilberto ; Kalemkerian, Gregory P ; Bowles, Daniel W ; Seetharam, Mahesh ; Chang, Jianhua ; Zhang, Hui ; Green, Jennifer ; Zalutskaya, Alena ; Schuler, Martin ; Fan, Yun ; Curigliano, Giuseppe

Nature medicine, 2022-08, Vol.28 (8), p.1640-1645 [Periódico revisado por pares]

United States: Nature Publishing Group

Texto completo disponível

4
RET Aberrations in Diverse Cancers: Next-Generation Sequencing of 4,871 Patients
Material Type:
Artigo
Adicionar ao Meu Espaço

RET Aberrations in Diverse Cancers: Next-Generation Sequencing of 4,871 Patients

Kato, Shumei ; Subbiah, Vivek ; Marchlik, Erica ; Elkin, Sheryl K ; Carter, Jennifer L ; Kurzrock, Razelle

Clinical cancer research, 2017-04, Vol.23 (8), p.1988-1997 [Periódico revisado por pares]

United States: American Association for Cancer Research Inc

Texto completo disponível

5
Addressing challenges with real-world synthetic control arms to demonstrate the comparative effectiveness of Pralsetinib in non-small cell lung cancer
Material Type:
Artigo
Adicionar ao Meu Espaço

Addressing challenges with real-world synthetic control arms to demonstrate the comparative effectiveness of Pralsetinib in non-small cell lung cancer

Popat, Sanjay ; Liu, Stephen V ; Scheuer, Nicolas ; Hsu, Grace G ; Lockhart, Alexandre ; Ramagopalan, Sreeram V ; Griesinger, Frank ; Subbiah, Vivek

Nature communications, 2022-06, Vol.13 (1), p.3500-3500, Article 3500 [Periódico revisado por pares]

London: Nature Publishing Group

Texto completo disponível

6
GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease
Material Type:
Artigo
Adicionar ao Meu Espaço

GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease

Wang, Dongdong ; Day, Emily A ; Townsend, Logan K ; Djordjevic, Djordje ; Jørgensen, Sebastian Beck ; Steinberg, Gregory R

Nature reviews. Endocrinology, 2021-10, Vol.17 (10), p.592-607 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

7
Tyrosine kinase inhibitors for solid tumors in the past 20 years (2001-2020)
Material Type:
Artigo
Adicionar ao Meu Espaço

Tyrosine kinase inhibitors for solid tumors in the past 20 years (2001-2020)

Huang, Liling ; Jiang, Shiyu ; Shi, Yuankai

Journal of hematology and oncology, 2020-10, Vol.13 (1), p.143-143, Article 143 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

8
Selpercatinib: First Approval
Material Type:
Artigo
Adicionar ao Meu Espaço

Selpercatinib: First Approval

Markham, Anthony

Drugs (New York, N.Y.), 2020-07, Vol.80 (11), p.1119-1124 [Periódico revisado por pares]

Cham: Springer International Publishing

Texto completo disponível

9
Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes
Material Type:
Artigo
Adicionar ao Meu Espaço

Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes

Drilon, Alexander ; Hu, Zishuo I ; Lai, Gillianne G Y ; Tan, Daniel S W

Nature reviews. Clinical oncology, 2018-03, Vol.15 (3), p.151-167 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

10
Pralsetinib: First Approval
Material Type:
Artigo
Adicionar ao Meu Espaço

Pralsetinib: First Approval

Markham, Anthony

Drugs (New York, N.Y.), 2020-11, Vol.80 (17), p.1865-1870 [Periódico revisado por pares]

Cham: Springer International Publishing

Texto completo disponível

Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (604)

Data de Publicação 

De até
  1. Antes de1996  (11)
  2. 1996Até2002  (101)
  3. 2003Até2009  (45)
  4. 2010Até2017  (129)
  5. Após 2017  (324)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (608)
  2. Japonês  (111)
  3. Croatian  (1)
  4. Chinês  (1)
  5. Norueguês  (1)
  6. Mais opções open sub menu

Buscando em bases de dados remotas. Favor aguardar.